Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
MDMA-Assisted Therapy Shows Safety and Efficacy for PTSD Treatment
02/17/2022
MDMA-assisted therapy is shown to be safe and efficacious in the treatment of severe PTSD, according to study results.
MDMA-assisted therapy is shown to be safe and efficacious in the treatment of severe PTSD, according to study results.
MDMA-assisted therapy is shown...
02/17/2022
Psych Congress Network
News
Significant Share of Young Adults With Substance Use Disorder Have Autistic Traits
02/16/2022
One in 5 young adults receiving outpatient treatment for a substance use disorder may have clinically elevated autistic traits, according to study findings published in The American Journal on Addictions.
One in 5 young adults receiving outpatient treatment for a substance use disorder may have clinically elevated autistic traits, according to study findings published in The American Journal on Addictions.
One in 5 young adults receiving...
02/16/2022
Psych Congress Network
News
Insomnia Remission Eases Adult ADHD Severity
02/16/2022
In adults with ADHD, remission of insomnia disorder was associated with major improvement in ADHD clinical severity 6 months later, according to a study published in Psychiatry Research.
In adults with ADHD, remission of insomnia disorder was associated with major improvement in ADHD clinical severity 6 months later, according to a study published in Psychiatry Research.
In adults with ADHD, remission...
02/16/2022
Psych Congress Network

Advertisement

News
Ketamine Increases Abstinence Days in Patients With Severe Alcohol Use Disorder
02/11/2022
Three weekly ketamine infusions were associated with more days of alcohol abstinence at a 6-month follow-up in patients with severe alcohol use disorder, according to a double-blind, phase 2 trial published in the American Journal of...
Three weekly ketamine infusions were associated with more days of alcohol abstinence at a 6-month follow-up in patients with severe alcohol use disorder, according to a double-blind, phase 2 trial published in the American Journal of...
Three weekly ketamine infusions...
02/11/2022
Psych Congress Network
News
Adults With ADHD May Benefit From Adjunctive Saffron
02/09/2022
Saffron may enhance methylphenidate efficacy in adults with ADHD, according to study findings.
Saffron may enhance methylphenidate efficacy in adults with ADHD, according to study findings.
Saffron may enhance...
02/09/2022
Psych Congress Network
News
Chatbots Show Potential to Prevent Eating Disorders
02/07/2022
In a recent study led by researchers from Palo Alto University and Washington University in St. Louis, a chatbot—a computer program that simulates human conversation—was found to potentially reduce the likelihood of an individual developing...
In a recent study led by researchers from Palo Alto University and Washington University in St. Louis, a chatbot—a computer program that simulates human conversation—was found to potentially reduce the likelihood of an individual developing...
In a recent study led by...
02/07/2022
Addiction Professional

Advertisement

News
Aripiprazole Augmentation Associated With Depression Remission Gains
02/04/2022
Aripiprazole augmentation of antidepressants may be an effective long-term strategy for the treatment of patients with refractory major depressive disorder, according to new research.
Aripiprazole augmentation of antidepressants may be an effective long-term strategy for the treatment of patients with refractory major depressive disorder, according to new research.
Aripiprazole augmentation of...
02/04/2022
Psych Congress Network
News
Addiction Medicine Consult for Hospitalized Patients Reduces 90-Day Mortality
02/04/2022
In-hospital addiction medicine consultations appear to reduce deaths among patients with substance use disorder, according to study results published in the Journal of General Internal Medicine.
In-hospital addiction medicine consultations appear to reduce deaths among patients with substance use disorder, according to study results published in the Journal of General Internal Medicine.
In-hospital addiction medicine...
02/04/2022
Psych Congress Network
News
Underrepresentation in Psychedelic Studies May Indicate Findings Cannot be Generalized
02/03/2022
Results from psychedelic medicine studies may not translate across ethnic groups as minorities are highly underrepresented in studies on the subject, according to a methodological search review published in BMC Psychiatry.
Results from psychedelic medicine studies may not translate across ethnic groups as minorities are highly underrepresented in studies on the subject, according to a methodological search review published in BMC Psychiatry.
Results from psychedelic...
02/03/2022
Psych Congress Network

Advertisement

News
Earlier Sleep Onset May Improve Hyperactivity/Inattention Symptoms in Some Children
02/03/2022
Delayed sleep onset was significantly associated with symptoms of hyperactivity and inattention in children with a low genetic risk of ADHD in a birth cohort of 8- and 9-year-olds.
Delayed sleep onset was significantly associated with symptoms of hyperactivity and inattention in children with a low genetic risk of ADHD in a birth cohort of 8- and 9-year-olds.
Delayed sleep onset was...
02/03/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use